IP Library Assignment 012662/0347
Patent Assignment
Reel/Frame 012662/0347

Assignment of Assignor's Interest

Recorded: 2002-03-04 Pages: 3
Assignors
ISOLA, JORMA
Executed: 2002-02-13
TANNER, MINNA
Executed: 2002-02-13
JARVINEN, TERO
Executed: 2002-02-13
SHI, ZUO-RONG
Executed: 2002-02-13
WU, RINA
Executed: 2002-02-13
Assignee
ZYMED LABORATORIES, INC.
458 CARLTON COURT, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property (1)
Identifying Subjects Suitabe for Tooisomerase Ii Inhibitor Treatment
Patent: 6,942,970 →
Application: 09/952,851 →
Publication: US 2003/0134279
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Oct 9, 2007
From: ZYMED LABORATORIES, INC.
To: INVITROGEN CORPORATION
Reel/Frame 019934/0695 →
Security Agreement Dec 5, 2008
From: LIFE TECHNOLOGIES CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 021975/0467 →
Merger Feb 3, 2010
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 023882/0551 →
Lien Release Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 030182/0461 →
Corrective Assignment to Correct the Application No 09452626 Previously Recorded on Reel 023882 Frame 0551. Assignor(S) Hereby Confirms the Merger Should Not Have Been Recorded Against This Patent Application Number. Nov 14, 2014
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 034217/0490 →